Abstract
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Introduction
2
According to the annual report of the World Health Organization in 2017, 10.5 3 million new cases and 1.7 million deaths were related to tuberculosis (TB), establishing TB 4 as the infectious disease with the greatest impact on human health. [1] 5 Close to 25% of TB cases recorded worldwide every year show resistance (DR-TB) 6 to at least one of the four antibiotics used in first line treatment against this disease; 7 Rifampicin (R), Isoniazid (H), Ethambutol (E) and Pyrazinamide (Z). Of these DR-TB 8 isolates, about 5% evolve into multi-drug resistant tuberculosis; i.e., they present a 9 combined resistance to isoniazid and rifampicin (MDR-TB), which may evolve into an 10 aggravated form known as extreme drug-resistant tuberculosis (TB-XDR), which are 11 isolates that possess simultaneous resistance to a flouroquinolone and at least one of the 12 three second-line injectable drugs (amikacin, kanamycin and capreomicin). The number of 13 isolates with these characteristics is steadily increasing, reducing the possibility of 14 eliminating TB as a global public health problem by 2020. [2] 15 Whole Genome Sequencing (WGS) provides accurate information about polymorphisms, 16 insertions and deletions (indels) of potential relevance to the rapid prediction of drug 17 susceptibility phenotypes of clinical importance [3, 4] . The implementation of WGS has 18 potential for improving traditional phenotypic procedures to detect DR-TB cases and to
19
influence clinical decision-making in high-income settings [5] [6] [7] [8] [9] [10] [11] , in addition, this 20 technique has also been successfully used to examine transmission dynamics, identify The current body of knowledge regarding mutations that confer drug resistance has led to 2 the suggestion that identification of true DR-TB isolates may be more complex than 3 previously thought [16] , raising the need to further this type of study in order to identify the 4 changes involved and increase diagnostic efficiency. Moreover, there is a lack of evidence 5 regarding the utility of WGS in emerging or poorly-developed countries, which are 6 precisely those most affected by drug-resistant tuberculosis, and where information relating 7 to the polymorphism associated with drug resistance is limited [6,17-21] 8 In Mexico, tuberculosis is endemic. According to the 2017 Global Report, 22,869 new 9 cases of TB were reported in 2016, with an incidence of 22 cases per 100,000 inhabitants 10 [1] . DR-TB cases were observed in 2.5% of these cases, and there was also a prevalent Mycobacterium tuberculosis strains were isolated in Lowenstein-Jensen media, and 9 sensitivity testing against first-line drugs was performed by the fluorometric method 10 (BACTEC MGIT 960, Becton-Dickinson) using the following critical concentrations: 11 isoniazid (H) 0.1μg/mL, rifampin (R) 1.0 μg/mL, ethambutol (E) 5.0 μg/mL and 12 streptomycin (S) 1.0 μg/mL. Pyrazinamide (Z) sensitivity was determined using BACTEC
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MGIT 960 PZA kit (Becton Dickinson). In order to classify the isolates, and to identify whether they had a specific genotype 11 and whether these were related, a phylogenetic analysis was performed. We classified all of 12 the strains according to the presence of the specific lineages or sub-lineages of phylogenetic 13 variants proposed by Coll et al. 2014 [36] and Stucki et al. 2016 [37] . In order to detect negative predictive values (NPV) were determined with 95% confidence intervals. Data 6 was analyzed using STATA V.13. Inter-test agreement for both results was expressed by 7 the percentage of overall agreement and kappa (κ) statistic, according to Landis et al. [40] . Four isolates presented M. fortuitum and two presented M. abscessus and it was not 7 possible to determine the species in a further four isolates. These ten isolates were therefore 8 excluded from the global study.
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Of the 81 individuals ultimately included in the study, 50% (42) were male, with a 10 mean age of 45 years (±14.6) and all individuals presented respiratory TB. A total of 36%
11
(31) presented type 2 diabetes mellitus (T2DM), 47% (40) were undergoing primary 12 treatment and 42% (36) presented a re-treatment.
13
In relation to the phenotypic drug resistance profile of the 81 isolates determined by 14 BACTEC MGIT assay, S resistance was observed in 47% (38) of the isolates, while H 15 resistance was presented in 75% (61), R resistance in 62% (n=51), E resistance in 29% (24) 16 and Z resistance in 34% (28) . A total of 25% (21) 
1673425 Intergenic ------c/t 9 Total 58* 10 * In combination with other mutation in a single isolate.
12
Of the 51 isolates that were rifampicin-resistant according to the BACTEC MGIT 13 phenotypic assay, 49 (96%) had a mutation in the rpoB gene. Some isolates presented more 1 than one mutation, while two isolates presented no mutations. One sensitive isolate, as 2 determined by the BACTEC assay, showed the rpoB430L/P mutation while another strain 3 had the mutation rpoB432Q/L. Thirteen mutations were observed, the most frequent of 4 which was found at rpoB450S/L in 35 (71%) of the isolates (Table 2) . of the resistant isolates showed no mutation, mine while six isolates, defined as sensitive by 11 the BACTEC MGIT phenotypic assay, showed one mutation related to resistance to this 12 drug. The most frequent mutation was observed at embB306M/V/I in eleven isolates, 1 followed by the embA promoter C-12T mutation at the intergenic genome position 2 4243221, which was observed in eight isolates (Table 3) . phenotypically identified as Z-susceptible presented a mutation that could be associated 9 with resistance. In total, 17 mutations were identified in pncA. The most frequent of these 10 was pncA120L/P, which was detected in 14 isolates (Table 4) . Of the 38 isolates with phenotypic S resistance, only eleven (29%) presented a 5 mutation that would explain the resistant condition (Table 5 ). The remaining 27 (71%) 6 isolates presented no change. Only one phenotypically-determined sensitive isolate showed 7 one polymorphism associated with resistance. Nine mutations were observed in three genes 8 (gidB, rpsL and rrs); the most abundant of which were rpsL43K/R and a c/t mutation at 9 position 1472362 on the rrs gene, both found in three isolates each. (Table 5) 10 1 isolates presented a mutation that would confer resistance to fluoroquinolones; ten had a 5 mutation at gyrA, conferring resistance to ofloxacin, and two had one mutation at gyrB, 6 conferring resistance to levofloxacin (Table 6 ). In addition, five isolates presented 7 mutations at eis and rrs, conferring resistance to kanamycin, amikacin and capreomycin. Finally, no polymorphisms were observed in genes associated with resistance to linezolid 9 (rrl and rplC), aminoglycosides (tlyA), ethionamide (ethR, mshA, inhA, ndh and ethA) and 10 p-amino salicylic acid (thyA).
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A joint analysis of MDR-TB isolates with the mutations related to resistance against 12 second-line drugs showed the presence of eight isolates that could potentially be considered 13 as pre-XDR-TB (with resistance to H and R, associated with resistance to FQ or a second- [27] [28] [29] [30] [42] [43] [44] .
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A sensitivity of 84%, specificity of 100% and kappa concordance of 88% were 21 determined for the diagnosis of resistance to H; these values are similar to that described in
22
reports from different locations [8] [9] [10] [11] 21] (Table. 7 ). Ten isolates showed no mutations that Isoniazid  84  100  85  98  90  97  87  99  100  94  97  99   Rifampicin  96  94  92  99  93  98  100  97  100  94  97  99   Ethambutol  71  90  82  95  90  92  79  99  100  78  94  94   Pyrazinamide  75  90  24  100  65  92  86  98  ----91  96   Streptomycin  29  98  82  99  80  91  73  100  85  100 ----
11
Sen= sensitivity, Spe=Specificity.
12
The sensitivity of 96% and specificity of 94% observed for the diagnostic of R by
13
WGS coincides with previous reports [8] [9] [10] [11] 21] (Table 7) . Two isolates were notable for 14 being phenotypically susceptible to rifampicin, despite the fact that they were carriers of the 15 mutations rpoB432Q/L and rpoB430L/P respectively, which have been considered as
16
"disputed mutations" [47] that confers low-level R resistance [48] . WGS, the mutations that explain that condition.
8
The sensitivity for the diagnosis of resistance to E by WGS was 71%, which is 9 one of the lowest described to date [8] [9] [10] [11] 21] (Table 7) . Seven resistant isolates showed no 10 mutations, while six sensitive isolates showed a mutation associated with resistance to this order to identify the factors that cause this low sensitivity and to improve the efficiency of 17 WGS in predicting resistance against this drug among the isolates from the setting.
18
The sensitivity of 75% observed for Z was low compared to other reports [8] [9] [10] [11] 21] 19 (Table 7) ; however, the specificity of 90% and kappa agreement of 84% supports the use of
20
WGS for the diagnosis of resistance to this drug. and indels observed in pncA was the highest among all of the genes studied, and was 4 similar to values previously described [29] . A deletion in the pncA47 position (2289101; -5 gttgc) and an insertion in pncA131 (2288850; +cc) were identified; both indels were 6 described in isolates circulating in the region five years ago [29] , raising the possibility that 7 these isolates are still actively circulating in the present population.
8
The 29% sensitivity observed for S through the WGS was among the lowest and specificity values exceeding 85% [6, 8, 10, 18, 53] . Thus, the possibility of generating a 10 faster screening diagnosis of pre-and XDR-TB strains using WGS could have important
11
implications for a middle-income country such as Mexico, where at least 6 to 12 months are 12 required to establish a sensitivity profile against second line drugs in isolates suspected of 13 having this condition.
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While it was only a relatively small number of isolates studied, four lineages were 15 identified; 90% (76) were placed in L4 (Euro-American), confirming the predominance of 16 this lineage in the population [24, 25, 41, 54, 55] and the presence of the "founder effect",
17
where the predominance of specific lineages seems to limit the dispersion of new or less 18 frequent lineages [55] [56] [57] . Twenty-six (32%) isolates were located within six transmission 19 clusters, of which two were particularly noteworthy: i) the TC1, which included the only 20 two isolates with L3 (CAS) and ii) the TC6, comprising 13 (17%) MDR-TB isolates with 21 sub-lineage 4.1.1 (X), including one isolate identified as pre-XDR-TB and another as XDR-
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TB. These CAS and X lineages are rarely referred in Mexico, particularly with such a 1 strong tendency towards drug resistance [24, 25, 41, 54, 58] and additional studies will be 2 necessary to determine the extension of this sub-lineages in the population.
3
The main limitation of this study probably relates to the fact that all of the isolates 
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In conclusion, this study illustrates the utility of WGS in terms of the diagnostic of 
